Floatz logo

9 assets in Lip And Oral Cavity Carcinoma

Therapeutic assets addressing Lip And Oral Cavity Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Cis-Diamminedichloroplatinum Ii
Lip And Oral Cavity Carcinoma
Loren Mell, MDP2B (60)
Nivolumab
Lip And Oral Cavity Carcinoma
National Cancer Institute (NCI)P2B (60)
Pembrolizumab
Lip And Oral Cavity Carcinoma
Loren Mell, MDP2CCC (53)
Brodalumab
Lip And Oral Cavity Carcinoma
Brian Henick, MDP1CC (43)
Cannabis Capsules
Lip And Oral Cavity Carcinoma
Tata Memorial HospitalP1CC (43)
99mTc-nanoscan
Lip And Oral Cavity Carcinoma
The Netherlands Cancer InstituteN/AD (30)
Icg-99Mtc-Nanoscan
Lip And Oral Cavity Carcinoma
The Netherlands Cancer InstituteN/AD (30)
Cabozantinib
Lip And Oral Cavity Carcinoma
National Cancer Institute (NCI)P2NR ()